Dr. Nadine Abi-Jaoudeh, MD
Claim this profileUniversity of California, Irvine
Area of expertise
Liver Cancer
Nadine Abi-Jaoudeh, MD has run 4 trials for Liver Cancer. Some of their research focus areas include:
Pancreatic Cancer
Nadine Abi-Jaoudeh, MD has run 3 trials for Pancreatic Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of California, Irvine
Chao Family Comprehensive Cancer Center, University Of California, Irvine
Clinical Trials Nadine Abi-Jaoudeh, MD is currently running
Radioembolization with EYE90 Microspheres
for Liver Cancer
This trial is testing Eye90 microspheres®, tiny beads with radioactive material, on patients with liver cancer that can't be removed by surgery. The beads deliver radiation directly to the tumor to kill cancer cells. Yttrium-90 microspheres have been increasingly used for treating liver cancers that cannot be surgically removed by delivering high doses of radiation directly to tumors.
Recruiting
1 award
N/A
Padeliporfin VTP
for Pancreatic Cancer
This is a prospective, multicenter, non-randomized, open label light dose escalation phase I trial to evaluate the safety and preliminary efficacy of Padeliporfin vascular targeted photodynamic therapy (VTP) applied via endovascular fiber placement within a dilatation catheter, through the superior mesenteric artery (SMA) in patients with stage III, locally advanced (LA) unresectable pancreatic ductal adenocarcinoma (PDAC). The investigators will evaluate safety and preliminary efficacy of Padeliporfin VTP administered endovascularly using light dose escalation.
Recruiting
1 award
Phase 1
6 criteria
More about Nadine Abi-Jaoudeh, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Nadine Abi-Jaoudeh, MD has experience with
- Padeliporfin VTP
- CtDNA Blood Collection
- Nivolumab Injectable Product
- Opdivo Injectable Product Or Keytruda Injectable Product
- Trans-arterial Tirapazamine Embolization
- NanoKnife System
Breakdown of trials Nadine Abi-Jaoudeh, MD has run
Liver Cancer
Pancreatic Cancer
Hepatocellular Carcinoma
Bile Duct Cancer
Ampullary Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nadine Abi-Jaoudeh, MD specialize in?
Nadine Abi-Jaoudeh, MD focuses on Liver Cancer and Pancreatic Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Nadine Abi-Jaoudeh, MD currently recruiting for clinical trials?
Yes, Nadine Abi-Jaoudeh, MD is currently recruiting for 4 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Nadine Abi-Jaoudeh, MD has studied deeply?
Yes, Nadine Abi-Jaoudeh, MD has studied treatments such as Padeliporfin VTP, ctDNA Blood Collection, Nivolumab Injectable Product.
What is the best way to schedule an appointment with Nadine Abi-Jaoudeh, MD?
Apply for one of the trials that Nadine Abi-Jaoudeh, MD is conducting.
What is the office address of Nadine Abi-Jaoudeh, MD?
The office of Nadine Abi-Jaoudeh, MD is located at: University of California, Irvine, Orange, California 92868 United States. This is the address for their practice at the University of California, Irvine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.